Schedule 13G ownership disclosure

Oramed Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 68403P203

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
972,000
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-20-001660
Form type
SC 13G/A
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Feb 14, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub